Depression: EU approves expanded use of esketamine for rapid reduction of symptoms
Why Black men’s prostate cancer may be more responsive to immunotherapy
10 February 2021Vaccine production must catch up to science: EU chief
10 February 2021Depression: EU approves expanded use of esketamine for rapid reduction of symptoms
Esketamine nasal spray—sold under the name Spravato—has been approved by the European Commission as a short term treatment for adults with a moderate to severe episode of major depressive…
